We use cookies to analyze the performance of our website. If you continue to visit our website you are consenting to our use of cookies.

Yes No More Info

ICRC-Weyer Ready For Increase In Advanced Therapy Trials

ICRC-Weyer’s recent participation in the NanoKTN meeting on September 5th proved to be informative and successful. Two members of the ICRC-Weyer team, Christina Richter and Dr. Iris Hardewig, attended the event which took place at the British Embassy in Berlin. The meeting provided a platform for biotech companies and service providers from the UK and Germany to present their work in the field of regenerative medicine and engage in discussions on potential co-operations with the other participants.

We use cookies to analyze the performance of our website. If you continue to visit our website you are consenting to our use of cookies.

Yes No More Info